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CDC Advises Hospitals to Alert Patients at Risk from Contaminated Heater-Cooler 
Devices Used during Cardiac Surgery 
 
Summary 
The Centers for Disease Control and Prevention (CDC) is advising hospitals to notify patients who 
underwent open-heart (open-chest) surgery involving a Stöckert 3T heater-cooler that the device was 
potentially contaminated, possibly putting patients at risk for a life threatening infection. New information 
indicates that these devices, manufactured by LivaNova PLC (formerly Sorin Group Deutschland GmbH), 
were likely contaminated with the rare bacteria Mycobacterium chimaera during manufacturing. Hospitals 
should advise potentially exposed patients to seek medical care if they are experiencing symptoms such 
as night sweats, muscle aches, unexplained weight loss, fatigue, or unexplained fever. In addition, 
hospitals that use or have used this device are strongly encouraged to make and execute a plan to 




In the spring of 2015, investigators in Switzerland reported a cluster of six patients with invasive infection 
of M. chimaera, a species of nontuberculous mycobacterium (NTM) commonly found in soil and water. 
The infected patients had undergone open-heart surgery that used contaminated heater-cooler devices 
during extracorporeal circulation (1). In July 2015, a Pennsylvania hospital also identified a cluster of 
invasive NTM infections among patients who had undergone open-heart surgery.  CDC assisted in a field 
investigation that used both epidemiologic and laboratory evidence to identify an association between 
invasive Mycobacterium avium complex (including M. chimaera) infections and exposure to contaminated 
3T heater-cooler devices, consistent with the Swiss report (2).  
 
The water circuits in these heater-cooler devices that are used to regulate temperature during 
cardiopulmonary bypass do not come into direct contact with the patient’s circulating blood; however, 
these reports suggest that M. chimaera can be aerosolized by the devices and result in infections (1,2). 
The Food and Drug Administration (FDA) and CDC have issued alerts about the need to follow updated 
manufacturer’s instructions for maintenance and use of the devices, evaluate the devices for 
contamination, remain vigilant for new infections, and continue to monitor reports from the United States 
and overseas (2). 
 
CDC in collaboration with National Jewish Health completed a whole-genome sequencing analysis and 
results demonstrate that M. chimaera isolates from patients with heater-cooler associated infections and 
from the 3T heater-cooler devices from several U.S. hospitals (in Pennsylvania and Iowa) are all highly 
related to each other (3). This evidence for likely point-source contamination of the 3T heater-cooler 
devices is consistent with recent reports from Europe 
(http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm504213.htm) that describe matching of 
M. chimaera sequences from environmental isolates at the device production site in Germany and 
isolates from patients and devices in Europe. 
 
More than 250,000 heart bypass procedures using heater-cooler devices are performed in the United 
States every year; the 3T heater-cooler device linked to these infections represents about 60% of the 
heater-cooler devices in the country (2,4). In hospitals where at least one infection has been identified, 
the risk of infection was between about 1 in 100 and 1 in 1,000 patients. Initial information suggests that 
patients who had prosthetic material implanted are at highest risk for NTM infections. These infections are 
difficult to treat and delays in diagnosis further complicate patients’ clinical management. Therefore , it is 
imperative that patients and providers are informed about the risk of infection associated with use of the 





1. Internists, infectious disease specialists, cardiologists, cardiothoracic surgeons , and other clinicians 
should suspect NTM infections among patients who have signs of infection and a history of open-
chest cardiac surgery.  
o Infections can take months to cause symptoms.  
o Patients with NTM infections following cardiac surgery have presented with a variety of 
clinical manifestations. Common examples are endocarditis, surgical site infection, or 
abscess and bacteremia. Other clinical manifestations have included hepatitis, renal 
insufficiency, splenomegaly, pancytopenia, and osteomyelitis.   
2. Diagnosis can be difficult due to the nonspecific presentation of illness and the slow growing nature of 
the bacteria.  
o Physicians should consider consulting with an infectious disease specialist if caring for 
patients who have undergone an open-chest cardiac procedure and present with signs of 
infection. 
o Cultures for acid fact bacilli (AFB) should be obtained as part of the evaluation.  
o Other specialized testing to detect M. chimaera may be needed and further laboratory testing 
should be discussed and arranged in consultation with an infectious disease specialist or 
health department. 
Hospitals 
1. Hospitals performing open-chest cardiac surgery should immediately assess their use of heater-
cooler devices and determine whether they are currently using – or have previously used – 3T 
devices.  Facilities should ensure that they are implementing current FDA recommendations to 
minimize patient risk to infections associated with heater-cooler devices 
(http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/UCM520191.htm).  
2. Hospitals should notify cardiothoracic surgeons, cardiologists, infectious disease physicians, 
internists, primary care physicians, and other clinicians who evaluate patients that have had open-
chest cardiac or other bypass surgery, about the risk of infection associated with 3T heater-cooler 
devices. CDC has sample letters available at https://www.cdc.gov/hai/outbreaks/heater-cooler.html.  
3. Hospitals should review their facility’s microbiology laboratory database and records of surgical 
procedures for any positive NTM cultures in surgery patients that might indicate a possible case.  
CDC has provided guidance on case-finding: http://www.cdc.gov/hai/pdfs/outbreaks/Guide-for-Case-
Finding.pdf. 
4. Hospitals should consider institution-specific strategies for alerting patients of the risk of infection 
related to potentially contaminated heater-cooler devices. CDC has sample patient notification letters 
available at https://www.cdc.gov/hai/outbreaks/heater-cooler.html. 
5. Hospitals can consider prospective surveillance of patients who have undergone open-chest cardiac 
surgery involving a 3T heater-cooler device. 
6. Hospitals should consider using informed consent to educate patients of the potential NTM infection 
risk. 
7. The overall risk of M. chimaera infection is low relative to other complications following cardiac 
surgery; emergent cardiac procedures should not be delayed because of the use of 3T devices. 
Continued use of 3T devices should be done in accordance with the latest manufacturer’s 
recommendations, including maintenance and proper positioning of devices to minimize the risk of 
patient exposure.  
8. Hospitals that have identified contaminated 3T heater-cooler devices or patient infections associated 
with devices should promptly alert their local or state health department and submit  a report to FDA 





1. Health departments should communicate with healthcare facilities that perform cardiac surgery using 
heater-cooler devices about the risk of M. chimaera infection associated with open-chest cardiac 
surgery involving use of the 3T heater-cooler devices.  Health departments should direct facilities to 
CDC and FDA heater-cooler guidance documents in these communications.  




o FDA guidance documents can be found here:  
 http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm504213.htm 
 http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm466963.htm 
 http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/UCM52019 1.htm 
 
2. Health departments should track reports from healthcare facilities about potential infections 
associated with heater-cooler devices and encourage facilities to report these events to FDA.  
3. Health departments should be prepared to assist healthcare facilities with further investigation; CDC 
is available for further consultation as needed. 
Patients 
1. Symptoms of NTM infection, including M. chimaera infection, can take months to appear. Patients 
should be aware of the symptoms of NTM infection which can include persistent  or unexplained fever; 
night sweats; redness, heat, or pus around a surgical incision; muscle aches; unexplained weight 
loss; or fatigue. 
2. Patients who have had cardiac surgery should seek medical evaluation if they have one or more of 
these symptoms or have questions about possible exposure to a heater-cooler device. 
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The Centers for Disease Control and Prevention (CDC) protects people's health and safety by preventing 
and controlling diseases and injuries; enhances health decisions by providing credible information on 
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